PEAK6 Investments’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $541K | Sell |
30,000
-27,666
| -48% | -$499K | ﹤0.01% | 423 |
|
|
2024
Q2 | $937K | Buy |
57,666
+2,798
| +5% | +$45.5K | ﹤0.01% | 332 |
|
|
2024
Q1 | $774K | Buy |
54,868
+27,161
| +98% | +$383K | ﹤0.01% | 345 |
|
|
2023
Q4 | $289K | Buy |
27,707
+12,000
| +76% | +$125K | ﹤0.01% | 624 |
|
|
2023
Q3 | $160K | Sell |
15,707
-166,003
| -91% | -$1.69M | ﹤0.01% | 732 |
|
|
2023
Q2 | $1.37M | Buy |
181,710
+142,520
| +364% | +$1.07M | 0.01% | 210 |
|
|
2023
Q1 | $347K | Sell |
39,190
-40,961
| -51% | -$363K | ﹤0.01% | 554 |
|
|
2022
Q4 | $731K | Sell |
80,151
-762,257
| -90% | -$6.95M | ﹤0.01% | 427 |
|
|
2022
Q3 | $6.8M | Buy |
842,408
+65,139
| +8% | +$526K | 0.03% | 70 |
|
|
2022
Q2 | $5.85M | Buy |
+777,269
| New | +$5.85M | 0.01% | 151 |
|
|
2022
Q1 | – | Sell |
-42,074
| Closed | -$337K | – | 2536 |
|
|
2021
Q4 | $337K | Buy |
42,074
+30,465
| +262% | +$244K | ﹤0.01% | 960 |
|
|
2021
Q3 | $113K | Sell |
11,609
-621
| -5% | -$6.05K | ﹤0.01% | 1308 |
|
|
2021
Q2 | $121K | Buy |
+12,230
| New | +$121K | ﹤0.01% | 1327 |
|
|
2021
Q1 | – | Sell |
-64,379
| Closed | -$621K | – | 2292 |
|
|
2020
Q4 | $621K | Sell |
64,379
-91,824
| -59% | -$886K | ﹤0.01% | 829 |
|
|
2020
Q3 | $1.41M | Buy |
156,203
+133,558
| +590% | +$1.2M | ﹤0.01% | 454 |
|
|
2020
Q2 | $279K | Sell |
22,645
-130,229
| -85% | -$1.6M | ﹤0.01% | 754 |
|
|
2020
Q1 | $1.37M | Sell |
152,874
-115,824
| -43% | -$1.04M | 0.01% | 296 |
|
|
2019
Q4 | $2.63M | Sell |
268,698
-31,223
| -10% | -$306K | 0.01% | 211 |
|
|
2019
Q3 | $2.06M | Sell |
299,921
-248,876
| -45% | -$1.71M | 0.01% | 270 |
|
|
2019
Q2 | $5.07M | Buy |
548,797
+307,405
| +127% | +$2.84M | 0.03% | 118 |
|
|
2019
Q1 | $3.79M | Buy |
+241,392
| New | +$3.79M | 0.02% | 156 |
|
|
2018
Q4 | – | Sell |
-130,967
| Closed | -$2.82M | – | 1805 |
|
|
2018
Q3 | $2.82M | Buy |
+130,967
| New | +$2.82M | 0.01% | 204 |
|